New heart drugs struggle to win sales as doctors hold back

LONDON, April 21 (Reuters) - New heart drugs hailed as breakthrough treatments by researchers are struggling to gain traction among prescribing doctors, posing a headache for makers such as Novartis, which reported more weak sales for its Entresto medicine on Thursday.